MP18-04 IMPACT OF PUTATIVE CHEMOPREVENTATIVE AGENTS ON PROSTATE CANCER DIAGNOSIS

Autor:	Thenappan Chandrasekar, Hanan Goldberg, Jaime Omar Herrera Cáceres, Shabbir M.H. Alibhai, Robert J. Hamilton, Christopher J.D. Wallis, Neil Fleshner, Alejandro Berlin, Girish S. Kulkarni, Ardalan Ahmed, Zachary Klaassen, Faizan K. Mohsin, Refik Saskin, Dixon T.S. Woon
Rok vydání:	2019
Předmět:	Oncology medicine.medical_specialty Prostate cancer business.industry Urology Internal medicine medicine Cancer medicine.disease business Cancer death
Zdroj:	Journal of Urology. 201
ISSN:	1527-3792 0022-5347
DOI:	10.1097/01.ju.0000555449.91087.2b
Popis:	INTRODUCTION AND OBJECTIVES:Prostate cancer (PC) is the most common non-cutaneous cancer in Canadian men and the third most common cause of cancer death in males accounting for 10% of all male canc...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6213c2a63118a9d348812d0155a0e9da https://doi.org/10.1097/01.ju.0000555449.91087.2b Zobrazit plný text záznamu